FTLF

 
Common Stock SEC Reporting - Current
Pink Current Information
Contact Info
  • 4509 S. 143rd Street
  • Suite 1
  • Omaha, NE 68137

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001374328
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Michael Abrams Interim CFO
John S. Wilson President, CEO
Warren Rothouse IR
Company Directors
Michael Abrams
Lewis Jaffe
Dayton Judd
Todd Ordal
John S. Wilson
Seth Yakatan
Service Providers
Accounting/Auditing Firm
Tarvaran Askelson & Company, LLP
35565 B Golden Lantern
Suite 509
Dana Point, CA, 92629
United States
 
Securities Counsel

Not Available
Investor Relations Firm
Network 1 Financial Securities
The Galleria Building, 2 Bridge Avenue
4th Floor
Red Bank, NJ, 07701
United States
 
Company History
  • Formerly=Bond Laboratories, Inc. until 9-2013
FTLF Security Details
Share Structure
Market Value1 $3,729,088 a/o Oct 19, 2017
Authorized Shares Not Available
Outstanding Shares 10,504,472 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Transfer Agent(s)
Shareholders
Shareholders of Record 231 a/o Apr 17, 2017
Short Selling Data
Short Interest 4,440 (2,437.14%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security